Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 139

    1.

    Intravitreal bevacizumab (Avastin) for the treatment of choroidal neovascularization in age-related macular degeneration: results from 118 cases.

    Madhusudhana KC, Hannan SR, Williams CP, Goverdhan SV, Rennie C, Lotery AJ, Luff AJ, Newsom RS.

    Br J Ophthalmol. 2007 Dec;91(12):1716-7. No abstract available. PMID: 18024821 [PubMed - indexed for MEDLINE]Related articles

    2.

    Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.

    Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA; Pan-American Collaborative Retina Study Group.

    Retina. 2008 Nov-Dec;28(10):1387-94.PMID: 18827735 [PubMed - indexed for MEDLINE]Related articles

    3.

    Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

    Retina. 2007 Apr-May;27(4):432-8.PMID: 17420694 [PubMed - indexed for MEDLINE]Related articles

    4.

    Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration.

    Aisenbrey S, Ziemssen F, Völker M, Gelisken F, Szurman P, Jaissle G, Grisanti S, Bartz-Schmidt KU.

    Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):941-8. Epub 2006 Dec 21.PMID: 17186262 [PubMed - indexed for MEDLINE]Related articles

    5.

    Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration.

    Lazic R, Gabric N.

    Graefes Arch Clin Exp Ophthalmol. 2007 Jan;245(1):68-73. Epub 2006 Nov 18.PMID: 17111146 [PubMed - indexed for MEDLINE]Related articles

    6.

    Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration using a variable frequency regimen in eyes with no previous treatment.

    Fong KC, Kirkpatrick N, Mohamed Q, Johnston RL.

    Clin Experiment Ophthalmol. 2008 Nov;36(8):748-55.PMID: 19128380 [PubMed - indexed for MEDLINE]Related articles

    7.

    Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

    Rich RM, Rosenfeld PJ, Puliafito CA, Dubovy SR, Davis JL, Flynn HW Jr, Gonzalez S, Feuer WJ, Lin RC, Lalwani GA, Nguyen JK, Kumar G.

    Retina. 2006 May-Jun;26(5):495-511.PMID: 16770255 [PubMed - indexed for MEDLINE]Related articles

    8.

    Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.

    Melamud A, Stinnett S, Fekrat S.

    Am J Ophthalmol. 2008 Jul;146(1):91-5. Epub 2008 May 2.PMID: 18455144 [PubMed - indexed for MEDLINE]Related articles

    9.

    Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

    Spaide RF, Laud K, Fine HF, Klancnik JM Jr, Meyerle CB, Yannuzzi LA, Sorenson J, Slakter J, Fisher YL, Cooney MJ.

    Retina. 2006 Apr;26(4):383-90.PMID: 16603955 [PubMed - indexed for MEDLINE]Related articles

    10.

    Intravitreal bevacizumab.

    Lucas RS, McKee HD, Lee LR.

    Ophthalmology. 2007 Feb;114(2):400; author reply 400-1. No abstract available. PMID: 17270701 [PubMed - indexed for MEDLINE]Related articles

    11.

    Visual improvement following intravitreal bevacizumab (Avastin) in exudative age-related macular degeneration.

    Yoganathan P, Deramo VA, Lai JC, Tibrewala RK, Fastenberg DM.

    Retina. 2006 Nov-Dec;26(9):994-8.PMID: 17151485 [PubMed - indexed for MEDLINE]Related articles

    12.

    Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.

    Smith BT, Dhalla MS, Shah GK, Blinder KJ, Ryan EH Jr, Mittra RA.

    Retina. 2008 May;28(5):675-81.PMID: 18463509 [PubMed - indexed for MEDLINE]Related articles

    13.

    Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.

    Emerson MV, Lauer AK, Flaxel CJ, Wilson DJ, Francis PJ, Stout JT, Emerson GG, Schlesinger TK, Nolte SK, Klein ML.

    Retina. 2007 Apr-May;27(4):439-44.PMID: 17420695 [PubMed - indexed for MEDLINE]Related articles

    14.

    Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.

    Dhalla MS, Shah GK, Blinder KJ, Ryan EH Jr, Mittra RA, Tewari A.

    Retina. 2006 Nov-Dec;26(9):988-93.PMID: 17151484 [PubMed - indexed for MEDLINE]Related articles

    15.

    Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.

    Ladas ID, Kotsolis AI, Papakostas TD, Rouvas AA, Karagiannis DA, Vergados I.

    Retina. 2007 Sep;27(7):891-6.PMID: 17891013 [PubMed - indexed for MEDLINE]Related articles

    16.

    Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to age-related macular degeneration in an Indian population.

    Azad RV, Khan MA, Chanana B, Azad S.

    Jpn J Ophthalmol. 2008 Jan-Feb;52(1):52-6. Epub 2008 Mar 28.PMID: 18369701 [PubMed - indexed for MEDLINE]Related articles

    17.

    Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation study.

    Costa RA, Jorge R, Calucci D, Cardillo JA, Melo LA Jr, Scott IU.

    Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4569-78.PMID: 17003454 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Same-day triple therapy with photodynamic therapy, intravitreal dexamethasone, and bevacizumab in wet age-related macular degeneration.

    Bakri SJ, Couch SM, McCannel CA, Edwards AO.

    Retina. 2009 May;29(5):573-8.PMID: 19430278 [PubMed - indexed for MEDLINE]Related articles

    19.

    Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

    Rosenfeld PJ, Moshfeghi AA, Puliafito CA.

    Ophthalmic Surg Lasers Imaging. 2005 Jul-Aug;36(4):331-5.PMID: 16156152 [PubMed - indexed for MEDLINE]Related articles

    20.

    Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration.

    Joeres S, Kaplowitz K, Brubaker JW, Updike PG, Collins AT, Walsh AC, Romano PW, Sadda SR.

    Ophthalmology. 2008 Feb;115(2):347-354.e2. Epub 2007 Jul 12.PMID: 17628685 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data